The rise of Viagra and its impact on the drug landscape presents a complicated question for investors. While the initial sales data were astounding, the patent has expired, leading to a flood of generic alternatives that are eroding profit. Moreover, the market is facing difficulties related to population trends and evolving healthcare regulatio… Read More